期刊论文详细信息
The British Journal of Nutrition
Genetic polymorphisms of key enzymes in folate metabolism affect the efficacy of folate therapy in patients with hyperhomocysteinaemia
Huizi Tian^11  Binghui Du^12 
[1]Department of Biostatistics and Bioinformatics,School of Public Health and Tropical Medicine,Tulane University,New Orleans,LA 70112,USA^2
[2]Department of Epidemiology,School of Public Health,Zhengzhou University,Zhengzhou 450001,Henan,People’s Republic of China^1
关键词: Hyperhomocysteinaemia;    Folate;    Efficacy;    Gene polymorphisms;   
DOI  :  10.1017/S0007114518000508
Subject:61.3
来源: Cambridge University Press
PDF
【 摘 要 】
The aim of this study is to analyse the efficacy rate of folate for the treatment of hyperhomocysteinaemia (HHcy) and to explore how folate metabolism-related gene polymorphisms change its efficacy. This study also explored the effects of gene–gene and gene–environment interactions on the efficacy of folate. A prospective cohort study enrolling HHcy patients was performed. The subjects were treated with oral folate (5 mg/d) for 90 d. We analysed the efficacy rate of folate for the treatment of HHcy by measuring homocysteine (Hcy) levels after treatment. Unconditioned logistic regression was conducted to analyse the association between SNP and the efficacy of folic acid therapy for HHcy. The efficacy rate of folate therapy for HHcy was 56·41 %. The MTHFR rs1801133 CT genotype, TT genotype and T allele; the MTHFR rs1801131 AC genotype, CC genotype and C allele; the MTRR rs1801394 GA genotype, GG genotype and G allele; and the MTRR rs162036 AG genotype and AG+GG genotypes were associated with the efficacy of folic acid therapy for HHcy (P 0·05). No association was seen between other SNP and the efficacy of folic acid. The optimal model of gene–gene interactions was a two-factor interaction model including rs1801133 and rs1801394. The optimal model of gene–environment interaction was a three-factor interaction model including history of hypertension, history of CHD and rs1801133. Folate supplementation can effectively decrease Hcy level. However, almost half of HHcy patients failed to reach the normal range. The efficacy of folate therapy may be genetically regulated.
【 授权许可】

CC BY   

【 预 览 】
附件列表
Files Size Format View
RO201911048068735ZK.pdf 326KB PDF download
  文献评价指标  
  下载次数:0次 浏览次数:1次